Comments on: Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform

Comments on: Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform https://9krapalm.com/illimis-therapeutics-closes-58-billion-krw-42-million-series-b-financing-to-accelerate-cns-and-immune-disease-drug-development-via-gaia-platform/ เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm Mon, 14 Jul 2025 07:59:22 +0000 hourly 1 https://wordpress.org/?v=7.0.4